Anciata Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Latest Deal Amount
-
$34M
- Investors
-
2
Anciata Therapeutics General Information
Description
Operator of a special purpose enterprise intended to advance an oral therapeutic candidate to clinical proof of concept for the treatment of autoimmune disorders. The company offers an orally administered therapeutic candidate developed for targeted clinical evaluation, enabling patients with autoimmune disorders access to an additional treatment option.
Contact Information
Corporate Office
- Basel
- Switzerland
Corporate Office
- Basel
- Switzerland
Anciata Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Joint Venture | 10-Apr-2025 | $34M | Completed | Startup |
Anciata Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cellestia | VC-Backed Company | Minority | ||
| TVM Capital Life Science | Venture Capital | Minority |
Anciata Therapeutics FAQs
-
When was Anciata Therapeutics founded?
Anciata Therapeutics was founded in 2025.
-
Where is Anciata Therapeutics headquartered?
Anciata Therapeutics is headquartered in Basel, Switzerland.
-
What industry is Anciata Therapeutics in?
Anciata Therapeutics’s primary industry is Drug Discovery.
-
Is Anciata Therapeutics a private or public company?
Anciata Therapeutics is a Private company.
-
What is Anciata Therapeutics’s current revenue?
The current revenue for Anciata Therapeutics is .
-
Who are Anciata Therapeutics’s investors?
Cellestia and TVM Capital Life Science have invested in Anciata Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process